Drug
VX 659 Tez Iva
VX 659 Tez Iva: highest development phase Phase 3, developed by Vertex Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Vertex Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| VX-659/TEZ/IVA NCT03447249 | Phase 3 | Cystic Fibrosis |
Latest
No recent events.
Follow VX 659 Tez Iva on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.